Trial Profile
YF476: Effects of Repeated Dosing at 2 Dose Levels on 24-hour Ambulatory Gastric pH Compared With Placebo and Omeprazole in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Netazepide (Primary) ; Omeprazole
- Indications Reflux oesophagitis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Trio Medicines
- 18 Apr 2015 New trial record